Biotia is a health tech company using sequencing and proprietary bioinformatics technology to reduce hospital-acquired infections. It develops and implements its diagnostic testing methods, including its AI-based software Chelsea™ and DNA sequencing for precision infectious disease detection and diagnosis. The company’s AI-based software can identify known and emerging bacteria, fungi, parasites and viruses from a clinically-curated and annotated database, as well as antimicrobial resistance genetic markers and virulence genetic markers. Chelsea’s engine offers a “precision metagenomic” test, including a complete report of the microbial profile and predicted drug resistance.